iPHEX 2013 pharma exhibition records over Rs 1000 crore profit
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) recently hosted iPHEX 2013, under the support of Ministry of Commerce and Industry, Department of Commerce, and Government of India. The three-day exhibition was inaugurated by Prithviraj Chavan, Chief Minister, Maharashtra and Rajeev Kher, Additional Secretary — Ministry of Commerce and Industry in the presence of Dr GN Singh, Drug Controller General of India (DCGI) and Mahesh Zagade, FDA Commissioner, Maharashtra. The exhibition witnessed a business turn over of Rs 1000 crores for the exhibitors.
iPHEX 2013 witnessed the presence of 250 stalls where pharmaceutical companies like Ranbaxy, Lupin, Glenmark, Mylan, MSN Labs, Ipca, Ind-Swift, Strides, Aurobindo, Mankind exhibited their products. Over 5,000 trade visitors including overseas buyer, delegates from highly regulated market like the US, Europe, Australia, New Zealand and 3,000 Pharmexcil registered members took part in the exhibition. Apart form this, over 500 overseas buyers were invited with the support of Ministry of Commerce and Industry Government of India.
Around 40 senior regulatory professionals from 20 countries like Ghana, Tanzania, Senegal, Taiwan, Vietnam, Philippine, Benin, Botswana, Burkina Faso, Egypt, Ghana, Niger, Nigeria, Seychelles, Uganda, Belaru, Haiti, Cuba, Dominic Republic, Mongolia, Sri Lanka, Zimbabwe and Health Ministry officials and drug regulator chiefs from Maharashtra, Andhra Pradesh, Gujarat, Karnataka were present for iPHEX-2013.
The presence of a large number of drug regulators from the overseas market immensely helped Pharmexcil and its members to promote the quality and affordability aspect as envisaged in Brand India Pharma Campaign. The campaign was initiated by Ministry of Commerce and executed by Pharmexcil in association with IBEF.
Dr PV Appaji, Director General, Pharmexcil said, “We have observed over 19,500 footfalls in the past three days. We were honoured to interact with the Indian and international regulators. The panel discussion supported the exhibitors as it discussed various issues faced by each other. Indian regulators assured that all the medicines to be exported from India will be better in terms of quality.”Bhavin Mehta Committee Chief, iPHEX and CoA member, Pharmexcil said, “The exhibition gave high opportunities and supported to explore new avenues. The international exhibitors were happy with the hospitality given by Pharmexcil and assured that there will be quantum leads of business for pharma industry in India.”
Besides iPHEX, PHARMA Pro and Pack Expo 2013 also saw a beeline of visitors. This expo provided an opportunity to join the industry majors from India and across the world at the technology show. It also proved to be a single point of contact to meet potential clients. PHARMA Pro and Pack Expo 2013 emerged as a very successful event providing excellent opportunity for technology exchange and marketing tie-ups.
EP News Bureau – Mumbai